Literature DB >> 3394585

Inhibition of passive cutaneous anaphylaxis by several histamine (H1) and serotonin antagonists in the rat.

J Metys1, H Frycová, R Soucek.   

Abstract

Drugs of the pizotifen type (pizotifen, cyproheptadine), possessing high H1-antihistamine and high antiserotonin activities in animal experiments, exert potent inhibitory actions on the passive cutaneous anaphylaxis (PCA) reaction in the rat. The drug pipethiadene, a 4,9-dihydrothieno(2,3-c)-2-benzothiepin derivative also belongs to this group. Selective histamine H1-antagonists alone are unable to cause pronounced reduction of the intensity of the PCA reaction in the rat, but in local reactions induced in rats by compound 48/80, histamine H1-receptors seem to play major role.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394585     DOI: 10.1007/bf02142579

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  THE MECHANISM OF ANAPHYLAXIS. I. PRODUCTION AND BIOLOGICAL PROPERTIES OF 'MAST CELL SENSITIZING' ANTIBODY.

Authors:  I MOTA
Journal:  Immunology       Date:  1964-11       Impact factor: 7.397

2.  The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.

Authors:  U Martin; D Römer
Journal:  Arzneimittelforschung       Date:  1978

3.  [Derivative of 4,9-dihydrothieno(2,3-b)benzo(e)thiepine--a new type of effective antihistaminic].

Authors:  J Metys; J Metysová
Journal:  Acta Biol Med Ger       Date:  1965

4.  [Pharmacological studies on the new antihistaminic Tavegil].

Authors:  D Römer; H Weidmann
Journal:  Med Welt       Date:  1966-12-17

5.  Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen).

Authors:  A K Dixon; R C Hill; D Roemer; G Scholtysik
Journal:  Arzneimittelforschung       Date:  1977

Review 6.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.